CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-16 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $114.02 | $2.3M | 121,835 |
| 2015-07-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −8,264 | 326,758 | ||
| 2015-07-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −11,736 | 315,022 | ||
| 2015-07-15 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $114.38 | $277K | 159,984 |
| 2015-07-15 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $114.35 | $277K | 159,984 |
| 2015-06-26 | Biller Scott Chief Scientific Officer | Exercise or conversion | +7,500 | $0.47 | $4K | 45,070 |
| 2015-06-26 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −7,500 | 307,380 | ||
| 2015-06-25 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $105.66 | $256K | 162,410 |
| 2015-06-25 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $105.66 | $256K | 162,410 |
| 2015-06-24 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $104.60 | $254K | 164,836 |
| 2015-06-24 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $104.59 | $254K | 164,836 |
| 2015-06-23 | Ho Maykin Director | Grant or award · Stock Option (right to buy) | +21,250 | 21,250 | ||
| 2015-06-23 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +10,625 | 23,125 | ||
| 2015-06-23 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +11,262 | 40,375 | ||
| 2015-06-23 | MARAGANORE JOHN Director | Grant or award · Stock option (right to buy) | +10,625 | 33,125 | ||
| 2015-06-23 | KARSEN PERRY A Director | Grant or award · Stock Option (right to buy) | +10,625 | 23,125 | ||
| 2015-06-23 | Foster-Cheek Kaye I Director | Grant or award · Stock Option (right to buy) | +11,899 | 36,899 | ||
| 2015-06-23 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +10,625 | 23,125 | ||
| 2015-06-23 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +11,900 | 49,400 | ||
| 2015-06-23 | Cantley Lewis Clayton Jr. Director | Grant or award · Stock option (right to buy) | +10,625 | 168,579 |
Page 89 of 93 · 1,853 trades